FDA
-
-
-
-
-
-
-
COSCIENS Biopharma (CSCI) Provides Corporate Update and Highlights Pipeline Prioritization
-
-
-
-
-
-
-
COSCIENS Biopharma (CSCI) Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
-
-
332,952 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


